Dr. Yasuo Takeda, Chairman of the Japanese Society of Hospital Pharmacists, has been appointed as an advisor to our company.
Press
New Year’s Greetings
We would like to extend our best wishes for the New Year
and express our sincere gratitude for your continued support over the past year.
In November of last year, we entered into a capital and business alliance with Medley Inc. and raised funds from M3 Inc. and other companies, with the aim of further promoting clinical trial digital transformation and maximizing the value of our services. Click
here for the press release.
Our product “StudyWorks,” which promotes digital transformation in clinical trials, has been adopted by over 40 hospitals by last year, primarily at university hospitals, cancer centers, and major group hospitals, with the aim of promoting digital transformation in clinical trial operations, improving case accumulation based on regional collaboration, and promoting DCT. This year, in light of the trends in the clinical trial ecosystem, we aim to further adopt the product in order to improve case accumulation starting from each facility and promote DCT.
This year, with a stronger management foundation, all of our employees are determined to work wholeheartedly to open up a new future for clinical trials through the power of technology.
We would appreciate your continued support this year.
I apologize for the abbreviated greeting on the corporate website, but I would like to take this opportunity to wish you a happy new year.
Thank you for your continued support this year.
New Year’s Day, 2026
Buzzreach Inc.
CEO Takateru Inokawa
Related Articles
-
-
Notice of New Year’s holiday closure and thanks for the year
-
Lecture report by the “StudyWorks®” Product Development Department Manager released – The challenge of developing a DCT platform in collaboration with clinical trial sites –
-
Published an article titled “Future Outlook for Digitalization of Clinical Trial Management: Considering the Benefits of Work Reduction Through System Use”
-
[Webinar] Eliminate the risk of not achieving your goals! “Regional Collaboration DCT” strategy to accelerate case registration
-
We will be exhibiting a corporate booth at the 57th Annual Meeting of the Japanese Society of Pediatric Respiratory Medicine.
-
Guidance and request for cooperation regarding the handling of clinical trial information when using the clinical trial support system “StudyWorks”
-
Published an article on the application of DCT (Decentralized Clinical Trials) in Japan and the future of DX in the clinical trial industry
-
Representative Ikawa will be speaking at the 22nd DIA Japan Annual Meeting 2025, and the company will have a booth.
-
A paper by our representative, Inogawa, was published in Volume 42, Issue 3 of Neurotherapeutics, the journal of the Japanese Society of Neurotherapeutics.